Cited by 808Gut microbiota and healthInflammatory Bowel DiseaseProbiotics and Fermented Foods

Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches

Open access
Sartor, R. Balfour, Wu, Gary D.·2017·Gastroenterology

Abstract

Intestinal microbiota are involved in the pathogenesis of Crohn's disease, ulcerative colitis, and pouchitis. We review the mechanisms by which these gut bacteria, fungi, and viruses mediate mucosal homeostasis via their composite genes (metagenome) and metabolic products (metabolome). We explain how alterations to their profiles and functions under conditions of dysbiosis contribute to inflammation and effector immune responses that mediate inflammatory bowel diseases (IBD) in humans and enterocolitis in mice. It could be possible to engineer the intestinal environment by modifying the microbiota community structure or function to treat patients with IBD-either with individual agents, via dietary management, or as adjuncts to immunosuppressive drugs. We summarize the latest information on therapeutic use of fecal microbial transplantation and propose improved strategies to selectively normalize the dysbiotic microbiome in personalized approaches to treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2016.10.012

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Probiotics may provide an option to mitigate some microbiome-related effects in IBD and help restore normal immune function by acting on intestinal gut barrier integrity.

    “Probiotics may provide an option to mitigate some microbiome-related effects in IBD and to help restore a normal immune function by acting on the intestinal gut barrier integrity for example (Sartor and Wu, 2017).”

    From Viral Infections, the Microbiome, and Probiotics (2021) · cites this paper as Sartor and Wu, 2017

  • Presence of some pathogenic microbes, such as invasive Escherichia coli, activates T helper 1 and T helper 17 cells thereby inducing mucosal damage.

    “The presence of some pathogenic microbes (e.g., invasive Escherichia coli) activate T helper 1 and T helper 17 cells thereby inducing mucosal damage (Sartor and Wu, 2017).”

    From Viral Infections, the Microbiome, and Probiotics (2021) · cites this paper as Sartor and Wu, 2017

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 177 · Cited by 808

Authors
Sartor, R. B., & Wu, G. D.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • University of Pennsylvania (US)
Corresponding author
  • Sartor, R. Balfour
  • Wu, Gary D.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2017-01
Volume
152
Issue
2
Pages
327-339.e4
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2534977774
Cited by
808
References
177
Citations by year
2026: 37 · 2025: 58 · 2024: 99 · 2023: 87 · 2022: 108 · 2021: 108 · 2020: 96 · 2019: 107 · 2018: 73 · 2017: 32 · 2016: 2 · 2015: 1
FWCI
6.46
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • UNC Libraries
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (P01DK094779)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
gut microbiota, inflammatory bowel disease, Crohn's disease, ulcerative colitis, pouchitis, dysbiosis, gut viruses, gut fungi, metagenome, metabolome, mucosal homeostasis, intestinal inflammation, immune response, fecal microbiota transplantation, dietary management, immunosuppressive therapy
MeSH terms
Gastrointestinal Microbiome, Animals, Bacteria, Colitis, Ulcerative, Crohn Disease, Fungi, Humans, Viruses, Inflammatory Bowel Diseases, Pouchitis, Metagenome, Metabolome, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review